Dr. Bradley Elliott Chipps, MD

Dr. Chipps practices at Capital Allergy and Respiratory Disease Center a Med Corp in Sacramento, California.

Dr. Chipps' NPI, 1073524740, was assigned on August 10, 2006. Dr. Chipps graduated from UTMB Health in 1972. Dr. Chipps holds California license C38640.

Dr. Chipps' primary practice is Capital Allergy and Respiratory Disease Center a Med Corp, at 5609 J St, Sacramento, CA 95819 in Sacramento County. The practice phone is (916) 453-8696.

Dr. Chipps' primary practice is Capital Allergy and Respiratory Disease Center a Med Corp in Sacramento, California. Dr. Chipps is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is Capital Allergy & Respiratory Disease Center. Dmand AI also links Dr. Chipps to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chipps practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Chipps' primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Chipps is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Chipps' licenses on file in 3 states: California, Texas and Maryland.

Dmand AI lists acute sinusitis, asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic sinusitis, hypersomnia, pneumonia and pulmonary fibrosis among the conditions Dr. Chipps treats.

CMS data shows 41,041 Medicare services from Dr. Chipps across 15 procedure codes in 2024, for 495 Medicare patients. Medicare paid $1,125,093 for them. Every service was in an office.

CMS counts 495 Medicare patients who saw Dr. Chipps in 2024. The largest group is 65 to 74, with 221 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chipps' median patient age at 27, with 49% women.

In 2024, Dr. Chipps wrote 4,672 Medicare Part D claims for 618 patients. CMS names the drug for 4,473 of them, across 60 drugs with 11 or more claims each, at $2,973,632 in total drug cost. In 2023, CMS named 5,450 claims across 63 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Chipps for performance year 2024, reported individually. Dr. Chipps accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chipps as offering telehealth.

Dmand AI links 173 papers to Dr. Chipps, published from 2007 to 2025. 2018 was the busiest year, with 13. The most frequent topics are Asthma, Anti-Asthmatic Agents and Adrenal Cortex Hormones. Dr. Chipps has published most often in Ann Allergy Asthma Immunol. Dr. Chipps' most frequent co-authors are Kevin R. Murphy, MD, Stanley Szefler, MD and Robert S. Zeiger, MD.

Dmand AI links Dr. Chipps to 2 clinical trials. Conditions studied include Asthma and Respiratory Hypersensitivity. Sanofi sponsors the most, 2. Open Payments lists research payments to Dr. Chipps that name 2 trials.

CMS Open Payments shows 1,775 general payments to Dr. Chipps from 49 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 47% of the total. AstraZeneca Pharmaceuticals LP paid the most, $523,379. It also lists 40 research payments totaling $53,942 from 2016 to 2022, naming 2 clinical trials.

Dmand AI lists 4 awards for Dr. Chipps, most recently Regional Top Doctor in 2014.

Dr. Chipps graduated from UTMB Health in 1972. Dr. Chipps is a member of AAAAI.

Dr. Chipps is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.